Heart Pump Devices Market Trends

ID: MRFR/MED/4576-HCR

100 Pages

Kinjoll Dey

October 2025

Heart Pump Devices Market Research Report Information, By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, And Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, and Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), and Others), By End-User (Hospi... read more

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Heart Pump Devices Market

In the recent years the market for heart pumps has been really in trend and this is due to the advancements that have been made in medical science and the higher prevalence of the diseases of the heart. The surge in VADs uptake presents one of the major recent trends as an alternative to surgical transplantation. These devices been known to be the most effective devices that offer the quality of life for patients waiting to be included in the list in for heart transplantation or those ineligible for transplantation. The market nowadays witnesses a growth in the demand of both intracorporeal and extra corporeal ventricle assist devices and giving users, the flexibility to choose among available options for their medical needs.

Technological innovations are critically important in the evolution of market patterns, in where the continuous efforts being made to enhance device performance and minimized invasiveness are constantly being pursued and improved. The requirement for the miniaturization of heart pumps has now become very demanding, which in turn leads to smaller devices, and therefore, procedures with little or no injury to patients and lower risk of complications. Many new materials and better designs have improved the life span of pumps by making them more durable and dependable. Thus, the heart pumps become more efficient and people live longer. Therefore, healthcare professionals are now incorporating technologies in an increased rate to enable them to offer more innovative treatments for patients who are suffering from heart failure that is already advanced.

A new trend (the destination therapy) in the implantable heart devices market is the given long term solution for patients with no transplant options to follow. VADs (ventricular assist devices) as destination therapy it always enables the patients to have active and improved living with their cardiac problems. This situation indicates the shift in the attitude of a ventricular assist devices from an emergency solution for a short period of time to a permanent one, liberating patients who might have otherwise no other choices.

Additionally, a collaboration and partnership between the vital participants in the industry would be seen as the major market trend recently. This co-operative approach intends to mobilize the accumulated competitiveness as well as the resources of the different stakeholders, for example, those working in the area of medical devices, healthcare providers and the scientific institutions. Collaboration, which is seen as a key driver, allows the cardiovascular industry and other stakeholders to develop the solutions that address the diverse and systemic problems related to cardiovascular diseases and thus deliver better treatment outcomes for patients.

Another market trend which is worth noting is the customer experience that consists of heightened awareness and use of digital means for the management of patients powered with heart pumps. These mechanics therefore correspond with the general movement in the sphere of digital health and patient-oriented care, and contribute to improvement of the situation in terms of patient experience and their adherence to therapies.

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

FAQs

What is the projected growth of the Heart Pump Devices market?

The Heart Pump Devices market is the expected increase in total market value of 6.31 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Heart Pump Devices market?

Heart Pump Devices market size was valued at approximately 0.74 billion USD in 2024. This figure will reach 6.31 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Heart Pump Devices market?

Heart Pump Devices market is expected to grow at a CAGR of 21.5% between 2025 and 2035.

How much will the Heart Pump Devices market be worth by 2035?

Heart Pump Devices market is expected to be worth of 6.31 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Heart Pump Devices market perform over the next 10 years?

Over the next 10 years the Heart Pump Devices market is expected to shift from usd billion 0.74 to 6.31 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

Which region held the largest market share in the Heart Pump Devices Market?

North America had the largest share of the market

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Heart Pump Devices Market was estimated at 741.16 USD Million in 2024. The Heart Pump Devices industry is projected to grow from 900.53 USD Million in 2025 to 6314.4 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 21.5 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Heart Pump Devices Market is experiencing robust growth driven by technological advancements and increasing healthcare investments.

Technological advancements are enhancing the efficacy and safety of heart pump devices, particularly in North America.
Minimally invasive procedures are gaining traction, leading to improved patient outcomes and shorter recovery times in the Asia-Pacific region.
Collaborative innovations among manufacturers and healthcare providers are fostering the development of advanced heart pump technologies.
The rising prevalence of cardiovascular diseases and increasing investment in healthcare infrastructure are key drivers propelling market growth.

Heart Pump Devices Market

CAGR

21.5%

Market Size & Forecast

2024 Market Size	741.16 (USD Million)
2035 Market Size	6314.4 (USD Million)
CAGR (2025 - 2035)	21.5%
Largest Regional Market Share in 2024	North America

Major Players

Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), CardiacAssist (US), Getinge (SE), LivaNova (GB), ReliantHeart (US), Cleveland Heart (US)

Market Trends

The Heart Pump Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of cardiovascular diseases. Innovations in device design and functionality are enhancing patient outcomes, while the growing aging population is contributing to a heightened demand for effective heart pump solutions. Furthermore, the integration of telemedicine and remote monitoring capabilities is reshaping how healthcare providers manage patients with heart conditions, potentially leading to improved adherence to treatment protocols and better overall health management. As the market evolves, regulatory bodies are also adapting to ensure that new devices meet safety and efficacy standards, which may influence the pace of innovation and market entry for new products. In addition, the Heart Pump Devices Market is witnessing a shift towards minimally invasive procedures, which are often associated with reduced recovery times and lower risk of complications. This trend is likely to attract both patients and healthcare providers seeking efficient treatment options. Moreover, collaborations between medical device manufacturers and technology firms are emerging, suggesting a future where artificial intelligence and machine learning could play a pivotal role in device functionality and patient monitoring. Overall, the Heart Pump Devices Market appears poised for growth, with various factors converging to enhance the landscape of cardiac care.

Technological Advancements

The Heart Pump Devices Market is seeing rapid technological advancements that enhance device performance and patient outcomes. Innovations such as improved materials, miniaturization, and smart technology integration are becoming more prevalent, potentially leading to more effective treatments.

Minimally Invasive Procedures

There is a noticeable trend towards minimally invasive procedures within the Heart Pump Devices Market. These techniques are associated with shorter recovery times and reduced complications, making them increasingly attractive to both patients and healthcare providers.

Collaborative Innovations

Collaborations between medical device manufacturers and technology companies are emerging in the Heart Pump Devices Market. This synergy may lead to the development of advanced solutions that incorporate artificial intelligence and machine learning, potentially revolutionizing patient monitoring and device functionality.

Heart Pump Devices Market Market Drivers

Market Growth Projections

The Global Heart Pump Devices Market Industry is projected to experience substantial growth over the coming years. With a market value of 0.74 USD Billion in 2024, it is anticipated to reach 5.6 USD Billion by 2035, reflecting a robust compound annual growth rate (CAGR) of 20.2% from 2025 to 2035. This growth trajectory indicates a strong demand for heart pump devices, driven by factors such as technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditures. The market's expansion is indicative of the critical role these devices play in modern cardiovascular care.

Rising Healthcare Expenditure

Global healthcare expenditure is on the rise, which positively impacts the Global Heart Pump Devices Market Industry. Increased funding allows for the adoption of advanced medical technologies, including heart pump devices, as healthcare systems strive to improve patient care. With a projected compound annual growth rate (CAGR) of 20.2% from 2025 to 2035, the market is poised for substantial growth. This financial commitment from governments and private sectors facilitates research and development, leading to innovative solutions that address the growing burden of cardiovascular diseases.

Increasing Geriatric Population

The aging population worldwide is a significant factor contributing to the growth of the Global Heart Pump Devices Market Industry. As individuals age, the risk of developing cardiovascular diseases increases, leading to a higher demand for heart pump devices. By 2035, the market is anticipated to expand significantly, driven by the needs of this demographic. The geriatric population often requires specialized care, and heart pump devices provide essential support for managing chronic heart conditions. This demographic shift underscores the necessity for healthcare systems to adapt and invest in advanced heart pump technologies.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases globally is a primary driver of the Global Heart Pump Devices Market Industry. As heart-related ailments continue to escalate, the demand for effective treatment options, including heart pump devices, rises correspondingly. With projections indicating that the market will reach 0.74 USD Billion in 2024, healthcare providers are compelled to adopt advanced technologies to manage these conditions. This trend is likely to persist, as cardiovascular diseases remain a leading cause of morbidity and mortality worldwide, necessitating innovative solutions to improve patient outcomes.

Growing Awareness and Education on Heart Health

There is a notable increase in awareness and education regarding heart health, which drives the Global Heart Pump Devices Market Industry. Public health campaigns and educational initiatives are informing individuals about the risks associated with cardiovascular diseases and the available treatment options. As patients become more informed, they are more likely to seek medical intervention, including the use of heart pump devices. This heightened awareness is expected to contribute to the market's growth, as more individuals recognize the importance of early diagnosis and treatment in managing heart conditions.

Technological Advancements in Heart Pump Devices

Technological innovations play a crucial role in shaping the Global Heart Pump Devices Market Industry. The development of miniaturized, more efficient, and biocompatible devices enhances patient comfort and outcomes. For instance, advancements in ventricular assist devices (VADs) have significantly improved their functionality and reliability. As these technologies evolve, they are expected to attract more investment and research, potentially leading to a market valuation of 5.6 USD Billion by 2035. The continuous evolution of these devices indicates a promising future for patients requiring mechanical circulatory support.

Market Segment Insights

By Application: Heart Failure (Largest) vs. Cardiac Surgery (Fastest-Growing)

The Heart Pump Devices Market exhibits diverse application segments, with Heart Failure commanding the largest share. This segment significantly eclipses others, reflecting its pressing clinical need due to the increasing prevalence of heart failure conditions globally. Meanwhile, the Cardiac Surgery segment is capturing attention as the fastest-growing area within the market, bolstered by advancements in surgical techniques and technology that enhance patient outcomes. This dynamic landscape emphasizes the importance of targeted solutions in managing specific conditions.

Heart Failure (Dominant) vs. Coronary Artery Disease (Emerging)

The Heart Failure segment remains the dominant player in the Heart Pump Devices Market, driven by the rising incidence of chronic heart conditions and the growing elderly population. Its established therapies and technologies cater to a significant number of patients, ensuring its leading position. In contrast, Coronary Artery Disease is emerging as a critical focus area, responding to innovative therapies and enhanced awareness. This segment's growth is fueled by increased screenings and diagnosis efforts, promoting early intervention and improving patient outcomes.

By Device Type: Left Ventricular Assist Device (Largest) vs. Intra-Aortic Balloon Pump (Fastest-Growing)

In the Heart Pump Devices Market, the Left Ventricular Assist Device (LVAD) holds a significant share, being the most widely adopted solution for patients with advanced heart failure. The increasing prevalence of heart diseases coupled with technological advancements in LVADs has solidified their position as a preferred treatment option among healthcare providers. Conversely, the Intra-Aortic Balloon Pump (IABP) is gaining traction, aimed primarily at acute coronary syndrome patients, and is recognized for its effectiveness in improving cardiac output and optimizing hemodynamics. As the Heart Pump Devices Market evolves, the LVAD continues to benefit from ongoing research and development, leading to improved device design and patient outcomes. Meanwhile, IABPs are experiencing faster adoption rates due to their minimally invasive nature and cost-effectiveness, making them more accessible. The growing emphasis on patient-centric care and innovative treatments is anticipated to drive further growth in these segments, encouraging a more significant market share for both LVADs and IABPs in the foreseeable future.

Left Ventricular Assist Device (Dominant) vs. Intra-Aortic Balloon Pump (Emerging)

The Left Ventricular Assist Device (LVAD) is a dominant player in the Heart Pump Devices Market, providing critical support for patients suffering from severe heart failure. These devices are designed to take over the pumping function of the left ventricle, allowing patients to maintain a better quality of life while awaiting heart transplants or as a long-term solution for heart failure management. Their established technology, comprehensive clinical backing, and adoption by healthcare systems worldwide highlight their prevalent role in cardiac care. In contrast, the Intra-Aortic Balloon Pump (IABP) represents an emerging segment within this market, gaining popularity due to its ability to augment myocardial perfusion and enhance coronary artery blood flow. With its relatively simple implementation and effectiveness in acute settings, IABPs are becoming increasingly recognized for their potential in enhancing patient outcomes post-cardiac procedures. The growing focus on minimally invasive therapies and advancements in balloon designs further position IABPs as a vital choice for clinicians aiming to optimize cardiac function in critically ill patients.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Heart Pump Devices Market, hospitals represent the largest end user segment, driven by the high volume of cardiac procedures performed in these settings. They account for a significant share of the overall market due to their capacity to offer advanced medical technologies and specialist care. Following closely, ambulatory surgical centers are gaining traction and driving innovation in the deployment of heart pump devices, contributing to an increasingly competitive landscape.

End User: Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals remain the dominant end user for heart pump devices, primarily due to their established infrastructure, experienced medical staff, and comprehensive patient management systems. They handle a vast array of cardiovascular conditions, necessitating advanced cardiac support devices to ensure optimal patient outcomes. On the other hand, ambulatory surgical centers are emerging rapidly in the market, capitalizing on the trend toward outpatient procedures. They offer a cost-effective alternative for surgical interventions and benefit from shorter recovery times. With advancements in minimally invasive techniques and technology, these centers are pivotal in expanding access to heart pump therapies and improving patient convenience.

Get more detailed insights about Heart Pump Devices Market Research Report – Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the Heart Pump Devices market, holding a significant share of 370.58M in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of new technologies, enhancing patient outcomes and driving market expansion. The competitive landscape in North America is robust, featuring key players such as Abbott, Medtronic, and Boston Scientific. These companies are at the forefront of technological advancements, offering a range of heart pump devices that cater to diverse patient needs. The presence of established healthcare systems and a high level of investment in medical technology contribute to the region's dominance in the global market.

Europe : Emerging Market with Growth Potential

Europe's Heart Pump Devices market is valued at 200.0M, reflecting a growing demand driven by an aging population and rising cardiovascular health issues. Regulatory frameworks in countries like Germany and France are evolving to support innovative medical devices, enhancing market accessibility. The European Medicines Agency (EMA) plays a crucial role in ensuring safety and efficacy, which fosters consumer confidence and drives market growth. Leading countries in this region include Germany, France, and the UK, where significant investments in healthcare technology are evident. Major players like Getinge and LivaNova are expanding their product offerings, focusing on minimally invasive solutions. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing technological capabilities and market reach, positioning Europe as a key player in The Heart Pump Devices.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific Heart Pump Devices market, valued at 150.0M, is experiencing rapid growth due to increasing healthcare expenditure and rising awareness of cardiovascular diseases. Countries like Japan and China are leading this growth, supported by government initiatives aimed at improving healthcare infrastructure. Regulatory bodies are also becoming more proactive in approving new technologies, which is essential for market expansion. In this region, key players such as Terumo and Boston Scientific are making significant inroads, focusing on innovative solutions tailored to local needs. The competitive landscape is evolving, with a mix of The Heart Pump Devices share. The increasing prevalence of heart diseases and the demand for advanced treatment options are driving the market forward, making Asia-Pacific a vital region for heart pump device manufacturers.

Middle East and Africa : Emerging Market with Challenges

The Heart Pump Devices market in the Middle East and Africa is valued at 20.58M, reflecting a nascent but growing sector. The market is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. However, challenges such as limited access to advanced medical technologies and varying regulatory environments can hinder growth. Governments are beginning to recognize the importance of cardiovascular health, leading to gradual improvements in healthcare policies. Countries like South Africa and the UAE are emerging as key players in this market, with investments in healthcare infrastructure and technology. Local and international companies are exploring opportunities to expand their presence, focusing on affordable and effective heart pump solutions. The competitive landscape is still developing, but the potential for growth is significant as awareness and healthcare access improve across the region.

Key Players and Competitive Insights

The Heart Pump Devices Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Abbott (US), Medtronic (US), and Boston Scientific (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Abbott (US) emphasizes the development of next-generation heart pump technologies, while Medtronic (US) is actively pursuing mergers and acquisitions to expand its product portfolio. Boston Scientific (US) is leveraging digital transformation initiatives to improve patient outcomes and streamline operations. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and patient-centric solutions.

Key business tactics within the Heart Pump Devices Market include localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several key players exerting significant influence. This fragmentation allows for a variety of innovative solutions to emerge, as companies strive to differentiate themselves through unique offerings and enhanced service delivery.

In November 2025, Abbott (US) announced the launch of its latest heart pump device, which integrates advanced AI algorithms to monitor patient conditions in real-time. This strategic move is likely to position Abbott as a leader in the market, as it addresses the growing demand for smart medical devices that enhance patient care and outcomes. The integration of AI not only improves device functionality but also aligns with broader trends towards digital health solutions.

In October 2025, Medtronic (US) completed the acquisition of a smaller firm specializing in minimally invasive heart pump technologies. This acquisition is significant as it expands Medtronic's capabilities in a niche segment of the market, allowing for a more comprehensive product offering. The move reflects Medtronic's commitment to innovation and its strategy to capture a larger share of the growing heart pump market.

In September 2025, Boston Scientific (US) entered into a strategic partnership with a leading telehealth provider to enhance remote monitoring capabilities for heart pump patients. This collaboration is indicative of the increasing importance of telehealth solutions in managing chronic conditions. By integrating telehealth with heart pump technologies, Boston Scientific aims to improve patient engagement and adherence to treatment protocols, thereby enhancing overall outcomes.

As of December 2025, current competitive trends in the Heart Pump Devices Market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming increasingly vital, as companies recognize the need to collaborate to drive innovation and improve patient care. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This transition underscores the importance of not only meeting patient needs but also ensuring that products are sustainable and aligned with the future of healthcare.

Key Companies in the Heart Pump Devices Market market include

Industry Developments

December 2022 Abiomed declares The two first patients are enrolled in the Impella ECP Pivotal Trial, which has already received FDA approval for the type of Impella ECP that will be utilized. The operations were directed by Amir Kaki, MD, head of mechanical circulatory support at Ascension St. John Hospital in Detroit.

January 2022 The world's most cutting-edge artificial heart, or Left Ventricular Assist Device (LVAD), is being developed, according to the School of Medical Research and Technology (SMRT), IIT-Kanpur.

Future Outlook

Heart Pump Devices Market Future Outlook

The Heart Pump Devices Market is projected to grow at a 21.5% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

New opportunities lie in:

Development of portable heart pump devices for home care settings.
Integration of AI for predictive analytics in heart pump management.
Expansion into emerging markets with tailored financing solutions.

By 2035, the Heart Pump Devices Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

Heart Pump Devices Market End User Outlook

Hospitals
Ambulatory Surgical Centers
Home Care Settings

Heart Pump Devices Market Application Outlook

Heart Failure
Cardiac Surgery
Coronary Artery Disease
Myocardial Infarction

Heart Pump Devices Market Device Type Outlook

Left Ventricular Assist Device
Right Ventricular Assist Device
Total Artificial Heart
Intra-Aortic Balloon Pump

Report Scope

MARKET SIZE 2024	741.16(USD Million)
MARKET SIZE 2025	900.53(USD Million)
MARKET SIZE 2035	6314.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	21.5% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), CardiacAssist (US), Getinge (SE), LivaNova (GB), ReliantHeart (US), Cleveland Heart (US)
Segments Covered	Application, Device Type, End User
Key Market Opportunities	Advancements in minimally invasive heart pump technologies enhance patient outcomes and expand market potential.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the Heart Pump Devices Market.
Countries Covered	North America, Europe, APAC, South America, MEA

FAQs

What is the projected growth of the Heart Pump Devices market?

What is the size of the Heart Pump Devices market?

What is the CAGR of the Heart Pump Devices market?

Heart Pump Devices market is expected to grow at a CAGR of 21.5% between 2025 and 2035.

How much will the Heart Pump Devices market be worth by 2035?

Heart Pump Devices market is expected to be worth of 6.31 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Heart Pump Devices market perform over the next 10 years?

Which region held the largest market share in the Heart Pump Devices Market?

North America had the largest share of the market

Report Prologue
Market Introduction
1. Definition
2. Scope Of The Study
  1. Research Objective
  2. Limitations
3. Assumptions
Research Methodology
1. Introduction
2. Primary Research
3. Secondary Research
4. Market Size Estimation
Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
4. Challenges
5. Macroeconomic Indicators
6. Technology Trends &
7. Assessment
8. Disease Prevalence And Diagnosis Analysis, By Country
9. Market Factor Analysis
10. Porter’s Five Forces Analysis
  1. Bargaining
  2. Bargaining Power Of Buyers
  3. Threat Of New
  4. Threat Of Substitutes
  5. Intensity Of Rivalry
11. Power Of Suppliers
12. Entrants
13. Value Chain Analysis
14. Investment Feasibility Analysis
15. Pricing Analysis
Global Heart Pump Devices Market, By Product
1. Introduction
2. Ventricular Assist Devices
3. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Left Ventricular Assist Devices
2. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Right Ventricular Assist Devices
2. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Bi-Ventricular Assist Devices
2. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Percutaneous Ventricular Assist Devices
2. • Market Estimates & Forecast,
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. • Market Estimates &
2. Forecast, 2023-2032
Transcutaneous Ventricular Assist Devices
• Market Estimates & Forecast, By Region/Country,
1. Intra-Aortic Balloon Pumps
2. • Market Estimates &
3. Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country,
1. Total Artificial Heart
2. • Market Estimates & Forecast,
• Market Estimates & Forecast, By Region/Country, 2023-2032
Global Heart Pump Devices Market, By Device Type
1. Introduction
2. Implantable Heart Pump Devices
3. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Extracorporeal Heart Pump Devices
2. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
Global
Heart Pump Devices Market, By Therapy
1. Introduction
2. Bridge-To-Candidacy
3. • Market Estimates & Forecast, 2023-2032
4. • Market Estimates
5. & Forecast, By Region/Country, 2023-2032
6. Bridge-To-Transplant
7. •
8. Market Estimates & Forecast, 2023-2032
9. • Market Estimates & Forecast,
10. By Region/Country, 2023-2032
11. Destination Therapy
12. • Market Estimates
13. & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country,
1. Others
2. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. •
Global Heart Pump Devices Market, By End-User
1. Introduction
2. Hospitals & Clinics
3. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Ambulatory Surgical Centers
2. • Market Estimates & Forecast, 2023-2032
• Market Estimates & Forecast, By Region/Country, 2023-2032
1. Research Institutes
2. • Market Estimates & Forecast, 2023-2032
3. •
Market Estimates & Forecast, By Region/Country, 2023-2032
1. Others
2. • Market Estimates & Forecast, 2023-2032
3. • Market Estimates
4. & Forecast, By Region/Country, 2023-2032
Global Heart Pump Devices Market,
1. By Region
2. Introduction
3. Americas
4. • Market Estimates
5. & Forecast, By Region, 2023-2032
6. • Market Estimates & Forecast,
7. By Product, 2023-2032
• Market Estimates & Forecast, By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market
2. Estimates & Forecast, By End-User, 2023-2032
3. •
North America
Market Estimates & Forecast, By Country, 2023-2032
1. • Market Estimates
2. & Forecast, By Product, 2023-2032
3. • Market Estimates & Forecast,
4. By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User, 2023-2032
U.S.
• Market Estimates & Forecast, By Product, 2023-2032
1. • Market
2. Estimates & Forecast, By Type, 2023-2032
3. • Market Estimates &
4. Forecast, By Therapy, 2023-2032
5. • Market Estimates & Forecast, By
6. End-User, 2023-2032
7. • Market Estimates & Forecast,
8. By Product, 2023-2032
Canada
• Market Estimates & Forecast, By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market
2. Estimates & Forecast, By End-User, 2023-2032
3. •
South America
Market Estimates & Forecast, By Product, 2023-2032
1. • Market Estimates
2. & Forecast, By Type, 2023-2032
3. • Market Estimates & Forecast,
4. By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User,
1. Europe
• Market Estimates & Forecast, By Region,
• Market Estimates & Forecast, By Product, 2023-2032
• Market Estimates & Forecast, By Type, 2023-2032
1. • Market
2. Estimates & Forecast, By Therapy, 2023-2032
3. • Market Estimates &
4. Forecast, By End-User, 2023-2032
5. • Market Estimates
6. & Forecast, By Country, 2023-2032
7. • Market Estimates & Forecast,
8. By Product, 2023-2032
Western Europe
• Market Estimates & Forecast, By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market
2. Estimates & Forecast, By End-User, 2023-2032
3. •
Germany
Market Estimates & Forecast, By Product, 2023-2032
1. • Market Estimates
2. & Forecast, By Type, 2023-2032
3. • Market Estimates & Forecast,
4. By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User,
France
• Market Estimates & Forecast, By Product,
• Market Estimates & Forecast, By Type, 2023-2032
1. •
Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market Estimates
2. & Forecast, By End-User, 2023-2032
3. • Market Estimates
4. & Forecast, By Product, 2023-2032
5. • Market Estimates & Forecast,
6. By Type, 2023-2032
U.K.
• Market Estimates & Forecast, By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User, 2023-2032
Italy
• Market Estimates & Forecast, By Product, 2023-2032
1. • Market
2. Estimates & Forecast, By Type, 2023-2032
3. • Market Estimates &
4. Forecast, By Therapy, 2023-2032
5. • Market Estimates & Forecast, By
6. End-User, 2023-2032
7. • Market Estimates & Forecast,
8. By Product, 2023-2032
Spain
• Market Estimates & Forecast, By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market
2. Estimates & Forecast, By End-User, 2023-2032
Rest Of Western Europe
• Market Estimates & Forecast, By Product, 2023-2032
1. • Market
2. Estimates & Forecast, By Type, 2023-2032
3. • Market Estimates &
4. Forecast, By Therapy, 2023-2032
5. • Market Estimates & Forecast, By
6. End-User, 2023-2032
7. • Market Estimates &
8. Forecast, By Product, 2023-2032
9. • Market Estimates & Forecast, By
10. Type, 2023-2032
Eastern Europe
• Market Estimates & Forecast, By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User, 2023-2032
1. Asia
2. Pacific
• Market Estimates & Forecast, By Country, 2023-2032
1. •
Market Estimates & Forecast, By Product, 2023-2032
1. • Market Estimates
2. & Forecast, By Type, 2023-2032
3. • Market Estimates & Forecast,
4. By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User,
Japan
• Market Estimates & Forecast, By Product,
• Market Estimates & Forecast, By Type, 2023-2032
1. •
Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market Estimates
2. & Forecast, By End-User, 2023-2032
3. • Market Estimates
4. & Forecast, By Product, 2023-2032
5. • Market Estimates & Forecast,
6. By Type, 2023-2032
China
• Market Estimates & Forecast, By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User, 2023-2032
India
• Market Estimates & Forecast, By Product, 2023-2032
1. • Market
2. Estimates & Forecast, By Type, 2023-2032
3. • Market Estimates &
4. Forecast, By Therapy, 2023-2032
5. • Market Estimates & Forecast, By
6. End-User, 2023-2032
7. • Market Estimates & Forecast,
8. By Product, 2023-2032
Australia
• Market Estimates & Forecast, By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market
2. Estimates & Forecast, By End-User, 2023-2032
Republic Of Korea
• Market Estimates & Forecast, By Product, 2023-2032
1. • Market
2. Estimates & Forecast, By Type, 2023-2032
3. • Market Estimates &
4. Forecast, By Therapy, 2023-2032
5. • Market Estimates & Forecast, By
6. End-User, 2023-2032
7. • Market Estimates
8. & Forecast, By Product, 2023-2032
9. • Market Estimates & Forecast,
10. By Type, 2023-2032
Rest Of Asia Pacific
• Market Estimates & Forecast, By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User, 2023-2032
1. The Middle
2. East & Africa
• Market Estimates & Forecast, By Region, 2023-2032
• Market Estimates & Forecast, By Product, 2023-2032
1. • Market
2. Estimates & Forecast, By Type, 2023-2032
3. • Market Estimates &
4. Forecast, By Therapy, 2023-2032
5. • Market Estimates & Forecast, By
6. End-User, 2023-2032
7. • Market Estimates
8. & Forecast, By Product, 2023-2032
9. • Market Estimates & Forecast,
10. By Type, 2023-2032
United Arab Emirates
• Market Estimates & Forecast, By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User, 2023-2032
1. Arabia
Saudi
• Market Estimates & Forecast, By Product, 2023-2032
1. •
Market Estimates & Forecast, By Type, 2023-2032
1. • Market Estimates
2. & Forecast, By Therapy, 2023-2032
3. • Market Estimates & Forecast,
4. By End-User, 2023-2032
5. • Market Estimates & Forecast,
6. By Product, 2023-2032
Oman
• Market Estimates & Forecast, By Type, 2023-2032
• Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market
2. Estimates & Forecast, By End-User, 2023-2032
3. •
Kuwait
Market Estimates & Forecast, By Product, 2023-2032
1. • Market Estimates
2. & Forecast, By Type, 2023-2032
3. • Market Estimates & Forecast,
4. By Therapy, 2023-2032
• Market Estimates & Forecast, By End-User,
Qatar
• Market Estimates & Forecast, By Product,
• Market Estimates & Forecast, By Type, 2023-2032
1. •
Market Estimates & Forecast, By Therapy, 2023-2032
1. • Market Estimates
2. & Forecast, By End-User, 2023-2032
3. Africa
Rest Of The Middle East &
• Market Estimates & Forecast, By Product, 2023-2032
1. •
Market Estimates & Forecast, By Type, 2023-2032
1. • Market Estimates
2. & Forecast, By Therapy, 2023-2032
3. • Market Estimates & Forecast,
4. By End-User, 2023-2032
Company Landscape
1. Introduction
2. Market Share Analysis
3. Key Development & Strategies
  1. Key
4. Developments
Company Profiles
1. Abbott Laboratories
  1. Product Overview
  2. Financials
2. Company Overview
3. SWOT Analysis
4. Abiomed
  1. Company Overview
  2. Product
  3. Financial Overview
  4. Key Developments
5. Overview
6. SWOT Analysis
7. Medtronic
  1. Company Overview
  2. Product
  3. Financial Overview
  4. Key Development
8. Overview
9. SWOT Analysis
10. Getinge
  1. Company Overview
  2. Product/Business
  3. Financial Overview
  4. Key Development
11. Segment Overview
12. SWOT Analysis
13. Syncardia Systems
  1. Company Overview
  2. Financial Overview
  3. Key Developments
14. Product Overview
15. Teleflex
  1. Company Overview
  2. Product Overview
  3. Key Developments
16. Financial Overview
17. Reliantheart
  1. Product Overview
  2. Financials
  3. Key Developments
  4. SWOT Analysis
18. Overview
19. Terumo
  1. Overview
  2. Product
  3. Financials
  4. Key Developments
  5. SWOT Analysis
20. Overview
21. Berlin Heart
  1. Overview
  2. Product Overview
  3. Key Developments
  4. SWOT Analysis
22. Financials
23. Jarvik
  1. Overview
  2. Product Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
24. Heart
25. Cardiacassist
  1. Overview
  2. Product Overview
  3. Financials
  4. SWOT Analysis
26. Key Developments
27. Fresenius Medical Care
  1. Overview
  2. Product Overview
  3. Financials
  4. SWOT Analysis
28. Key Developments
29. Thoratec Corporation
  1. Product Overview
  2. Financials
  3. Key
  4. SWOT Analysis
30. Overview
31. Developments
32. HeartWare
  1. Overview
  2. Product Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
33. MAQUET GmbH & Co
  1. Overview
  2. Product Overview
  3. Financials
  4. Key Developments
  5. SWOT Analysis
Appendix
LIST OF TABLES
Heart
1. Pump Devices Industry Synopsis, 2023-2032
Global Heart Pump Devices
1. Market Estimates And Forecast, 2023-2032, (USD Million)
Global Heart
Pump Devices Market, By Region, 2023-2032, (USD Million)
Global Heart
Pump Devices Market, By Type, 2023-2032, (USD Million)
Global Heart
Pump Devices Market, By Product, 2023-2032, (USD Million)
Global Heart
Pump Devices Market, By Therapy, 2023-2032, (USD Million)
Global Heart
Pump Devices Market, By End-Users, 2023-2032, (USD Million)
North America
Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
North
America Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
1. Table
North America Heart Pump Devices Market, By Product, 2023-2032, (USD Million)
North America Heart Pump Devices Market, By End-Users, 2023-2032, (USD
1. Million)
U.S. Heart Pump Devices Market, By Type, 2023-2032, (USD
1. Million)
U.S. Heart Pump Devices Market, By Therapy, 2023-2032, (USD
1. Million)
U.S. Heart Pump Devices Market, By Product, 2023-2032, (USD
1. Million)
U.S. Heart Pump Devices Market, By End-Users, 2023-2032,
1. (USD Million)
Canada Heart Pump Devices Market, By Type, 2023-2032,
1. (USD Million)
Canada Heart Pump Devices Market, By Product, 2023-2032,
1. (USD Million)
Canada Heart Pump Devices Market, By Therapy, 2023-2032,
1. (USD Million)
Canada Heart Pump Devices Market, By End-Users, 2023-2032,
1. (USD Million)
South America Heart Pump Devices Market, By Type, 2023-2032,
1. (USD Million)
South America Heart Pump Devices Market, By Therapy,
South America Heart Pump Devices Market,
1. By End-Users, 2023-2032, (USD Million)
Europe Heart Pump Devices Market,
1. By Type, 2023-2032, (USD Million)
Europe Heart Pump Devices Market,
1. By Therapy, 2023-2032, (USD Million)
Europe Heart Pump Devices Market,
1. By End-Users, 2023-2032, (USD Million)
Western Europe Heart Pump Devices
Market, By Type, 2023-2032, (USD Million)
Western Europe Heart Pump
Devices Market, By Therapy, 2023-2032, (USD Million)
Western Europe
Heart Pump Devices Market, By End-Users, 2023-2032, (USD Million)
1. Table 26
Eastern Europe Heart Pump Devices Market, By Type, 2023-2032, (USD Million)
1. Table
Eastern Europe Heart Pump Devices Market, By Therapy, 2023-2032, (USD Million)
Eastern Europe Heart Pump Devices Market, By End-Users, 2023-2032, (USD
1. Million)
Asia Pacific Heart Pump Devices Market, By Type, 2023-2032,
1. (USD Million)
Asia Pacific Heart Pump Devices Market, By Therapy,
Asia Pacific Heart Pump Devices Market, By
1. End-Users, 2023-2032, (USD Million)
Middle East & Africa Heart
Pump Devices Market, By Type, 2023-2032, (USD Million)
Middle East
& Africa Heart Pump Devices Market, By Diagnoses, 2023-2032, (USD Million)
Middle East & Africa Heart Pump Devices Market, By End-Users, 2023-2032,
1. (USD Million)
LIST OF FIGURES
Research Process
Segmentation For Global Heart Pump Devices Market
Segmentation
1. Market Dynamics For Heart Pump Devices Market
Global Heart Pump Devices
Market Share, By Type 2020
Global Heart Pump Devices Market Share,
1. By Product 2020
Global Heart Pump Devices Market Share, By End-Users,
Global Heart Pump Devices Market Share, By Region, 2020
1. Figure
North America Heart Pump Devices Market Share, By Country, 2020
1. Figure 9
Europe Heart Pump Devices Market Share, By Country, 2020
Asia Pacific
Heart Pump Devices Market Share, By Country, 2020
Middle East &
Africa Heart Pump Devices Market Share, By Country, 2020
Global Heart
1. Pump Devices Market: Company Share Analysis, 2020 (%)
Abbott Laboratories:
1. Key Financials
Abbott Laboratories: Segmental Revenue
1. Figure
Abbott Laboratories: Geographical Revenue
Medtronic. Key Financials
Medtronic: Segmental Revenue
Medtronic: Geographical
1. Revenue
Terumo: Key Financials
Terumo: Segmental Revenue
Terumo: Geographical Revenue
Getinge: Key Financials
Getinge: Segmental Revenue
Getinge: Geographical Revenue
Teleflex: Key Financials
Teleflex: Segmental Revenue
Teleflex. Geographical Revenue
Abiomed. Key Financials
Abiomed. Segmental Revenue
Abiomed. Geographical Revenue
Cardiacassist. Key Financials
Cardiacassist. Segmental
1. Revenue
Cardiacassist. Geographical Revenue

Heart Pump Devices Market Segmentation

Heart Pump Devices Product Outlook (USD Billion, 2018-2032)

Ventricular assist devices
Left ventricular assist devices
Right ventricular assist devices
Bi- ventricular assist devices
Percutaneous ventricular assist devices
Transcutaneous ventricular assist devices
Intra-Aortic balloon pumps
Total artificial heart

Heart Pump Devices, Device type Outlook (USD Billion, 2018-2032)

Implantable heart pump devices
Extracorporeal heart pump devices

Heart Pump Devices Therapy Outlook (USD Billion, 2018-2032)

Bridge-to-candidacy (BTC)
Bridge-to-transplant (BTC)
Destination therapy (DT)
Others

Heart Pump Devices End-user Outlook (USD Billion, 2018-2032)

Hospitals & Clinics
Ambulatory surgical centers
Research institutes
Others

Heart Pump Devices Regional Outlook (USD Billion, 2018-2032)

North America Outlook (USD Billion, 2018-2032)
- North America Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- North America Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- North America Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- North America Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- US Outlook (USD Billion, 2018-2032)
- US Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- US Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- US Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- US Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- CANADA Outlook (USD Billion, 2018-2032)
- CANADA Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- CANADA Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- CANADA Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- CANADA Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
Europe Outlook (USD Billion, 2018-2032)
- Europe Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Europe Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Europe Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- Europe Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Germany Outlook (USD Billion, 2018-2032)
- Germany Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Germany Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Germany Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- Germany Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- France Outlook (USD Billion, 2018-2032)
- France Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- France Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- France Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- France Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- UK Outlook (USD Billion, 2018-2032)
- UK Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- UK Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- UK Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- UK Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- ITALY Outlook (USD Billion, 2018-2032)
- ITALY Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- ITALY Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- ITALY Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination therapy (DT)
  - Others
- ITALY Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- SPAIN Outlook (USD Billion, 2018-2032)
- Spain Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Spain Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Spain Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Spain Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Rest Of Europe Outlook (USD Billion, 2018-2032)
- Rest Of Europe Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- REST OF EUROPE Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- REST OF EUROPE Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- REST OF EUROPE Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
Asia-Pacific Outlook (USD Billion, 2018-2032)
- Asia-Pacific Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Asia-Pacific Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Asia-Pacific Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Asia-Pacific Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- China Outlook (USD Billion, 2018-2032)
- China Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- China Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- China Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- China Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Japan Outlook (USD Billion, 2018-2032)
- Japan Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Japan Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Japan Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Japan Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- India Outlook (USD Billion, 2018-2032)
- India Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- India Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- India Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- India Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Australia Outlook (USD Billion, 2018-2032)
- Australia Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Australia Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Australia Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Australia Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
- Rest of Asia-Pacific Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Rest of Asia-Pacific Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Rest of Asia-Pacific Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Rest of Asia-Pacific Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
Rest of the World Outlook (USD Billion, 2018-2032)
- Rest of the World Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Rest of the World Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Rest of the World Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Rest of the World Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Middle East Outlook (USD Billion, 2018-2032)
- Middle East Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Middle East Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Middle East Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Middle East Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Africa Outlook (USD Billion, 2018-2032)
- Africa Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Africa Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Africa Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Africa Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others
- Latin America Outlook (USD Billion, 2018-2032)
- Latin America Heart Pump Devices by Product
  - Ventricular assist devices
  - Left ventricular assist devices
  - Right ventricular assist devices
  - Bi- ventricular assist devices
  - Percutaneous ventricular assist devices
  - Transcutaneous ventricular assist devices
  - Intra-Aortic balloon pumps
  - Total artificial heart
- Latin America Heart Pump Devices by Device type
  - Implantable heart pump devices
  - Extracorporeal heart pump devices
- Latin America Heart Pump Devices by Therapy
  - Bridge-to-candidacy (BTC)
  - Bridge-to-transplant (BTC)
  - Destination Therapy (DT)
  - Others
- Latin America Heart Pump Devices by End-user
  - Hospitals & Clinics
  - Ambulatory surgical centers
  - Research institutes
  - Others

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓

Heart Pump Devices Market Trends

Market Trends

Key Emerging Trends in the Heart Pump Devices Market

Market Highlights

Leave a Comment

FAQs

Market Summary

Key Market Trends & Highlights

Market Size & Forecast

Major Players

Market Trends

Technological Advancements

Minimally Invasive Procedures

Collaborative Innovations

Heart Pump Devices Market Market Drivers

Market Growth Projections

Rising Healthcare Expenditure

Increasing Geriatric Population

Rising Prevalence of Cardiovascular Diseases

Growing Awareness and Education on Heart Health

Technological Advancements in Heart Pump Devices

Market Segment Insights

By Application: Heart Failure (Largest) vs. Cardiac Surgery (Fastest-Growing)

By Device Type: Left Ventricular Assist Device (Largest) vs. Intra-Aortic Balloon Pump (Fastest-Growing)

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

Get more detailed insights about Heart Pump Devices Market Research Report – Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

Europe : Emerging Market with Growth Potential

Asia-Pacific : Rapidly Growing Healthcare Sector

Middle East and Africa : Emerging Market with Challenges

Key Players and Competitive Insights

Key Companies in the Heart Pump Devices Market market include

Industry Developments

Future Outlook

Heart Pump Devices Market Future Outlook

Market Segmentation

Heart Pump Devices Market End User Outlook

Heart Pump Devices Market Application Outlook

Heart Pump Devices Market Device Type Outlook

Report Scope

FAQs

Heart Pump Devices Product Outlook (USD Billion, 2018-2032)

Heart Pump Devices, Device type Outlook (USD Billion, 2018-2032)

Heart Pump Devices Therapy Outlook (USD Billion, 2018-2032)

Heart Pump Devices End-user Outlook (USD Billion, 2018-2032)

Heart Pump Devices Regional Outlook (USD Billion, 2018-2032)

North America Outlook (USD Billion, 2018-2032)

Europe Outlook (USD Billion, 2018-2032)

France Outlook (USD Billion, 2018-2032)

Asia-Pacific Outlook (USD Billion, 2018-2032)

Rest of the World Outlook (USD Billion, 2018-2032)

Free Sample Request

Related Reports

Customer Strories

Customer Stories

Compare Licence